Stomach cancer mortality in the future: where are we going?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Does hospital volume affect outcomes after abdominal cancer surgery: an analysis of Swiss health insurance claims data.BMC health services research · 2022
   Article
2. Incidence Trend of Gastrointestinal Cancer in Markazi, in the Center of Iran, Population-Based Cancer Registry Results: 2010-2014.Journal of gastrointestinal cancer · 2021
   Article
3. FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway.American journal of translational research · 2016
   Article
4. Challenges of deciphering gastric cancer heterogeneity.World journal of gastroenterology · 2015
   Review
5. Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance.American journal of cancer research · 2015
   Article
6. Can Barker's Hypothesis Explain the Observed Different Trends of Mortality from Atherosclerotic Cardiovascular Disease in Western Europe?International journal of preventive medicine · 2013
   Article
7. Can salt hypothesis explain the trends of mortality from stroke and stomach cancer in Western europe?International journal of preventive medicine · 2012
   Article
8. Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo.Experimental & molecular medicine · 2011
   Article

Corrections and comments

• Retraction · 2014-07-01Notice - Limited or No Information ·
• Retracted
  Retraction notice.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.